Roxanne Altemus
Psychiatric/Mental Health · Johnstown, PANPI 1851527949
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 491 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 44.7% of the total. Among psychiatric/mental health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 491 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Teva Pharmaceuticals USA, Inc.$930
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$790
- Otsuka America Pharmaceutical, Inc.$694
- Alkermes, Inc.$399
- Axsome Therapeutics, Inc.$387
- plus $1K from 11 others
What the payments were for
- Food & beverage$7,67898%
- Education$1882%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 264 | $3,514 |
| Teva Pharmaceuticals USA, Inc. | 68 | $930 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $790 |
| Otsuka America Pharmaceutical, Inc. | 33 | $694 |
| Alkermes, Inc. | 21 | $399 |
| Axsome Therapeutics, Inc. | 14 | $387 |
| Johnson & Johnson | 16 | $293 |
| Lundbeck LLC | 13 | $216 |
| Boston Scientific | 1 | $117 |
| Impel Pharmaceuticals Inc. | 1 | $113 |
| Corium, LLC | 7 | $110 |
| Vanda Pharmaceuticals Inc. | 5 | $91 |
| Neurocrine Biosciences, Inc. | 5 | $81 |
| E.r. Squibb & Sons, L.L.C. | 2 | $60 |
| Eisai Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
| OWP Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$238
- CAPLYTA$125
- Auvelity$125
- ABILIFY ASIMTUFII$123
- ABILIFY MAINTENA$123
- WATCHMAN Access System$117
- Trudhesa$113
How this compares
$7,866 in reported general payments places this provider in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $96,055 |
| VraylarCariprazine Hcl | 41 | $58,884 |
| Abilify MaintenaAripiprazole | 11 | $31,931 |
| LybalviOlanzapine/Samidorphan Malate | 11 | $17,082 |
| AuvelityDextromethorphan Hbr/Bupropion | 20 | $14,835 |
| TrintellixVortioxetine Hydrobromide | 14 | $6,212 |
| Aripiprazole | 38 | $3,200 |
| Fluphenazine Decanoate | 13 | $1,686 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 36 | $1,549 |
| Clozapine | 40 | $1,366 |
| Fluvoxamine Maleate | 11 | $901 |
| Vilazodone Hcl | 14 | $838 |
| Atomoxetine Hcl | 12 | $794 |
| Trazodone Hcl | 38 | $646 |
| Divalproex Sodium | 36 | $638 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $81 | $96,05511 claims |
| AbbVieVraylar | $3,514 | $58,88441 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $694 | $31,93111 claims |
| Alkermes, Inc.Lybalvi | $399 | $17,08211 claims |
| Axsome Therapeutics, Inc.Auvelity | $387 | $14,83520 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $24 | $6,21214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
Other psychiatric/mental health in Johnstown
- Tammy DunnJohnstown$14K
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.